Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Hooper

Showing results (131-140 of 171) with videos related to

Pageof 18
Sort By:
Antimicrobial Agents and Chemotherapy|May 4, 2022
A Tribute to George A. JacobyKaren Bush, David C Hooper, Robert A Bonomo, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 16, 2024
Biofilm formation by <i>Staphylococcus aureus</i> is triggered by a drop in the levels of a cyclic dinucleotideAdnan K Syed, Rishika Baral, Erik R Van Vlack, et al.
Scientific Reports|August 25, 2016
Chiral light intrinsically couples to extrinsic/pseudo-chiral metasurfaces made of tilted gold nanowiresAlessandro Belardini, Marco Centini, Grigore Leahu, et al.
Infection Control and Hospital Epidemiology|August 27, 2020
Healthcare worker infection with SARS-CoV-2 and test-based return to workErica S Shenoy, Lauren R West, David C Hooper, et al.
The Journal of Infectious Diseases|February 25, 2016
Antimicrobial Blue Light Inactivation of Gram-Negative Pathogens in Biofilms: In Vitro and In Vivo StudiesYucheng Wang, Ximing Wu, Jia Chen, et al.
Lasers in Surgery and Medicine|July 23, 2024
Blue Light Compromises Bacterial β-Lactamases Activity to Overcome β-Lactam ResistanceCarolina Dos Anjos, Yin Wang, Que Chi Truong-Bolduc, et al.
Virulence|February 25, 2016
Antimicrobial blue light inactivation of Candida albicans: In vitro and in vivo studiesYunsong Zhang, Yingbo Zhu, Jia Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2014
Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremiaMark J Siedner, Alicia Galar, Belisa B Guzmán-Suarez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2017
Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership GroupYohei Doi, Robert A Bonomo, David C Hooper, et al.
Open Forum Infectious Diseases|July 21, 2025
Infection Risk Associated With Colonization by Multidrug-Resistant Gram-Negative Bacteria: An Umbrella Review and Meta-analysisEdwin Wilbur Woodhouse, Majd Alsoubani, David J Roach, et al.
Pageof 18

Showing results (131-140 of 171) with videos related to

Sort By:
Pageof 18
Antimicrobial Agents and Chemotherapy|May 4, 2022
A Tribute to George A. JacobyKaren Bush, David C Hooper, Robert A Bonomo, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 16, 2024
Biofilm formation by <i>Staphylococcus aureus</i> is triggered by a drop in the levels of a cyclic dinucleotideAdnan K Syed, Rishika Baral, Erik R Van Vlack, et al.
Scientific Reports|August 25, 2016
Chiral light intrinsically couples to extrinsic/pseudo-chiral metasurfaces made of tilted gold nanowiresAlessandro Belardini, Marco Centini, Grigore Leahu, et al.
Infection Control and Hospital Epidemiology|August 27, 2020
Healthcare worker infection with SARS-CoV-2 and test-based return to workErica S Shenoy, Lauren R West, David C Hooper, et al.
The Journal of Infectious Diseases|February 25, 2016
Antimicrobial Blue Light Inactivation of Gram-Negative Pathogens in Biofilms: In Vitro and In Vivo StudiesYucheng Wang, Ximing Wu, Jia Chen, et al.
Lasers in Surgery and Medicine|July 23, 2024
Blue Light Compromises Bacterial β-Lactamases Activity to Overcome β-Lactam ResistanceCarolina Dos Anjos, Yin Wang, Que Chi Truong-Bolduc, et al.
Virulence|February 25, 2016
Antimicrobial blue light inactivation of Candida albicans: In vitro and in vivo studiesYunsong Zhang, Yingbo Zhu, Jia Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2014
Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremiaMark J Siedner, Alicia Galar, Belisa B Guzmán-Suarez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2017
Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership GroupYohei Doi, Robert A Bonomo, David C Hooper, et al.
Open Forum Infectious Diseases|July 21, 2025
Infection Risk Associated With Colonization by Multidrug-Resistant Gram-Negative Bacteria: An Umbrella Review and Meta-analysisEdwin Wilbur Woodhouse, Majd Alsoubani, David J Roach, et al.
Pageof 18